1 study found for:    16636120 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Alendronate;   Drug: Risedronate 35 mg;   Dietary Supplement: Elemental Calcium;   Dietary Supplement: Vitamin D;   Drug: Risendronate placebo;   Drug: Alendronate placebo

Indicates status has not been verified in more than two years